Replies to post #66617 on PharmaCyte Biotech Inc (PMCB)

[rudygerner]

I'm not so sure about that efood. I think the IND filing will move pps. Keep in mind, this trial isn't just going to be another exploratory trial, the upcoming trial will have pivotal status - positive results then equate to regulatory approval and future revenue. Having said that, once the IND is filed, the company waits the obligatory thirty days then the trial can begin. This is why the IND now requires more prep time, because the trial has been upgraded in status. Once the IND is filed, there is no turning back, and the company wants total and complete silence from the FDA during the obligatory thirty day waiting period. The only way to help ensure that is to make sure it is done right.

[Peacefulwendy]

I tend to agree with you efood. Shorts have been masterful at keeping this down. I think it is going to take big money investors to get this really moving upward. I don't even know if it will be the start of trials as much as the 60 stop. That is when there will be no doubt and the shorts will not be able to hold it down. However, I also think PMCB could be bought out before the 60 day stop if any big pharma have NDEs with PMCB. All just my opinion based on my observations over the past three years...